JCR is strengthening corporate governance for sustainable corporate value creation.
JCR Group considers that for the purpose of providing superior quality and more useful pharmaceutical products and medical equipment to society, it is important to aim to enhance the legality, transparency and objectivity of the Company’s management, to heighten our corporate value further, and at the same time to build a system to ensure the protection of the interests of shareholders. For this purpose, we are putting forth effort to secure implementation and operation of effective internal control systems, to evaluate the effectiveness of such systems on our own, and to fulfill social responsibilities as a corporation.
JCR as a company with the Audit & Supervisory Board, has established the Board of Directors consisting of nine Directors, including four Outside Directors, the Audit & Supervisory Board consisting of five Outside Audit & Supervisory Board Members, and Accounting Auditors. In addition to these organs, we have established the Management Control Committee, Advisory Committee for Nomination, Compensation, etc., Management Committee, Internal Audit Department, Internal Control Committee, Compliance Committee, and Safety and Health Committee. As for the composition of the corporate governance system, we believe it covers an appropriate scope in line with the Company’s current condition, and that it is possible to conduct efficient management operations. Also, we judge that the current governance system, which includes four Outside Directors and five Outside Audit & Supervisory Board Members is effective for ensuring management transparency, objectivity (impartiality) and independence of supervision over management.
Please refer to “Corporate Governance” for details.
JCR has established a Compliance Committee as an organization to implement and promote company management in line with social norms and corporate ethics as well as compliance with laws and regulations. The Committee consists of two sub-committees: a Compliance Control Committee chaired by Toru Ashida, Director and Chief Compliance Officer with committee members including our Directors and Corporate Officers, as well as external experts; and a Compliance Promotion Committee comprising employees nominated by the Compliance Control Committee members and assigned by President Shin Ashida. To promote compliance at JCR, the Compliance Committee holds meetings on a regular basis, determines the Company’s compliance action plans and policies, and provides employee training and education in accordance with the Compliance Code of Conduct and the Compliance Handbook, along with making compliance matters more widely known and raising awareness through a compliance newsletter.
Please refer to “Compliance” for details.
As a company that handles pharmaceutical products that concern people’s health, JCR has established procedures for risk control in each of its divisions along with ascertaining risk in corporate activities. It also determines basic risk management guidelines and develops its risk management system based on those guidelines. Furthermore, the Company is creating systems that can respond to risk prevention, risk management, and risk contingencies through collaboration with related committees such as the Risk Management Promotion Office, Internal Control Committee and Compliance Committee.
Risk Management System
JCR has listed the important risks it should be aware of and selected and decided on the three items below as Business Continuity Plan (BCP) items. The BCP is reviewed each fiscal year and revised if needed.
- 1. Response measures for Growject® supply in the event of disruption
- 2. Company-wide response measures in the event of a large-scale disaster
- 3. Response measures in the event of a major compliance violation
In particular, as a pharmaceutical company, JCR regularly holds meetings of the three roles in manufacturing and marketing (those responsible for overall manufacturing and marketing, quality assurance, and safety management) in accordance with laws and regulations, and has constructed systems that assure the quality, effectiveness and safety of drugs.
Moreover, while expanding its operations globally, JCR will introduce a global-standard drug quality system and pursue an even higher level of safety.